Archives of Critical Care Medicine

Published by: Kowsar

Deep Vein Thrombosis Prophylaxis Evaluation in Intensive Care Unit

Banafsheh Nekoonam 1 , Azadeh Eshraghi 2 , Mohammadreza Hajiesmaeili 3 and Zahra Sahraei 4 , *
Authors Information
1 Student Research Committee, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Clinical Pharmacy, Faculty of Pharmacy-International Campus, Iran University of Medical Sciences, Tehran, IR Iran
3 Anesthesiology Research Center, Anesthesia and Critical Care Department, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Critical Care Medicine: November 2016, 1 (4); e8497
  • Published Online: November 28, 2015
  • Article Type: Research Article
  • Received: September 30, 2015
  • Accepted: November 14, 2015
  • DOI: 10.17795/accm-8497

To Cite: Nekoonam B, Eshraghi A, Hajiesmaeili M, Sahraei Z. Deep Vein Thrombosis Prophylaxis Evaluation in Intensive Care Unit, Arch Crit Care Med. 2016 ; 1(4):e8497. doi: 10.17795/accm-8497.

Copyright © 2015, Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005; 51(2-3): 70-8[DOI][PubMed]
  • 2. Sharif-Kashani B, Mohebi-Nejad A, Abooturabi SM. Estimated Prevalence of Venous Thromboembolism in Iran: Prophylaxis Still an Unmet Challenge. Tanaffos. 2015; 14(1): 27-33[PubMed]
  • 3. Motykie GD, Zebala LP, Caprini JA, Lee CE, Arcelus JI, Reyna JJ, et al. A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis. 2000; 9(3): 253-62[PubMed]
  • 4. A scoring system for thromboembolic risk assessment in surgery, developed by the Polish Working Group, on the basis of the scoring system developed by Joseph Caprini. Acta Angiologica. 2011; 17(1): 49-76
  • 5. Section I: Deep Vein Thrombosis and Pulmonary Embolism as Major Public Health Problems. 2008;
  • 6. Ludwig KP, Simons HJ, Mone M, Barton RG, Kimball EJ. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients. Ann Pharmacother. 2011; 45(11): 1356-62[DOI][PubMed]
  • 7. Armahizer MJ, Benedict NJ, June L. FAST HUG: ICU prophylaxis. Am Soc Heal Pharm Forum. 2011; : 1-11
  • 8. Yang SD, Liu H, Sun YP, Yang DL, Shen Y, Feng SQ, et al. Prevalence and risk factors of deep vein thrombosis in patients after spine surgery: a retrospective case-cohort study. Sci Rep. 2015; 5: 11834[DOI][PubMed]
  • 9. Gaspard D, Vito K, Schorr C, Hunter K, Gerber D. Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically Ventilated Patients. Thrombosis. 2015; 2015: 849142[DOI][PubMed]
  • 10. Pannucci CJ, Bailey SH, Dreszer G, Fisher Wachtman C, Zumsteg JW, Jaber RM, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011; 212(1): 105-12[DOI][PubMed]
  • 11. Zeitoun AA, Dimassi HI, El Kary DY, Akel MG. An evaluation of practice pattern for venous thromboembolism prevention in Lebanese hospitals. J Thromb Thrombolysis. 2009; 28(2): 192-9[DOI][PubMed]
  • 12. Jetha L. A drug usage review of therapeutic doses of enoxaparin at Barnet and Chase Farm Hospitals. 2007;
  • 13. Fahimi F, Baniasadi SH, Behzadnia N, Varahram F, Ghazi Tabatabaie L. Enoxaparin utilization evaluation: An observational prospective study in medical inpatients. Iran J Pharm Res. 2010; : 77-82
  • 14. McCormick EW, Parbuoni KA, Huynh D, Morgan JA. Evaluation of Enoxaparin Dosing and Monitoring in Pediatric Patients at Children's Teaching Hospital. J Pediatr Pharmacol Ther. 2015; 20(1): 33-6[DOI][PubMed]
  • 15. Singh V, Gopinath K, Behzadpour A, Meera NK. Anticoagulant Utilization Evaluation in a Tertiary Care Teaching Hospital: An Observational Prospective Study in Medical in Patients. Indian J Pharm Practice. 2015; 8(2): 61-6[DOI]
  • 16. Khalili H, Dashti-Khavidaki S, Talasaz AH, Najmedin F, Hosseinpoor R. Anticoagulant utilization evaluation in a teaching hospital: a prospective study. J Pharm Pract. 2010; 23(6): 579-84[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments